Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Cancer Research|December 21, 2013
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomasDario Sangiolo, Giulia Mesiano, Loretta Gammaitoni, et al.
International Journal of Molecular Sciences|September 23, 2022
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GISTErika Fiorino, Alessandra Merlini, Lorenzo D'Ambrosio, et al.
Cancers|July 2, 2021
Crosstalk between Macrophages and Myxoid Liposarcoma Cells Increases Spreading and Invasiveness of Tumor CellsMichele Minopoli, Sabrina Sarno, Lucia Cannella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2016
Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem CellsLoretta Gammaitoni, Lidia Giraudo, Marco Macagno, et al.
Molecular Cancer|April 30, 2017
PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical modelsYmera Pignochino, Federica Capozzi, Lorenzo D'Ambrosio, et al.
European Journal of Cancer (Oxford, England : 1990)|April 28, 2017
Impact of a risk-based follow-up in patients affected by gastrointestinal stromal tumourLorenzo D'Ambrosio, Erica Palesandro, Paola Boccone, et al.
Frontiers in Oncology|September 16, 2022
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combinationAlessandra Merlini, Maria Laura Centomo, Giulio Ferrero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 9, 2020
CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma HistotypesValeria Leuci, Chiara Donini, Giovanni Grignani, et al.
The Lancet. Oncology|September 16, 2018
Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma GroupGiovanni Grignani, Lorenzo D'Ambrosio, Ymera Pignochino, et al.
Frontiers in Oncology|May 1, 2020
Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working GroupDominga Racanelli, Monica Brenca, Davide Baldazzi, et al.
Pageof 6